Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Services industry

Age Related Macular Degeneration Amd Therapeutics Market 2020 By Manufacturers, Regions, Types, Applications And Forecast To 2026

  • Code : SMI27243
  • Pages : 90
  • Date : Aug, 2020
  • Category : Services
  • Publisher : SMI
  • Format : SMI PPT FormatSMI PDF Format

  • Purchase Options

 

Summary

The global Age Related Macular Degeneration Amd Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Age Related Macular Degeneration Amd Therapeutics Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Age Related Macular Degeneration Amd Therapeutics Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Amgen Inc.
  • Bausch Health Companies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • ...

By the Product Type, the market is primarily segmented into:

  • Wet AMD
  • Dry AMD

By Applications, the market is segmented into:

  • Hospital
  • Clinic
  • Research Institute
  • Other

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Age Related Macular Degeneration Amd Therapeutics Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Age Related Macular Degeneration Amd Therapeutics Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Age Related Macular Degeneration Amd Therapeutics Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Age Related Macular Degeneration Amd Therapeutics Market

The Age Related Macular Degeneration Amd Therapeutics Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Age Related Macular Degeneration Amd Therapeutics Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Wet AMD
1.4.3 Dry AMD
1.5 Market by Application
1.5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Age-Related Macular Degeneration (AMD) Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Age-Related Macular Degeneration (AMD) Therapeutics Industry
1.6.1.1 Age-Related Macular Degeneration (AMD) Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Age-Related Macular Degeneration (AMD) Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Age-Related Macular Degeneration (AMD) Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Perspective (2015-2026)
2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions
2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Age-Related Macular Degeneration (AMD) Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Market Size
3.1.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio
3.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019
3.3 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served
3.4 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
3.5 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2021-2026)

5 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
6.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in North America (2019-2020)
6.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
6.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
7.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
8.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in China (2019-2020)
8.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
8.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
9.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
10.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
11.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in India (2019-2020)
11.3 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
11.4 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
12.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Details
13.1.2 Amgen Inc. Business Overview and Its Total Revenue
13.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020))
13.1.5 Amgen Inc. Recent Development
13.2 Bausch Health Companies, Inc.
13.2.1 Bausch Health Companies, Inc. Company Details
13.2.2 Bausch Health Companies, Inc. Business Overview and Its Total Revenue
13.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.2.5 Bausch Health Companies, Inc. Recent Development
13.3 F. Hoffmann-La Roche Ltd.
13.3.1 F. Hoffmann-La Roche Ltd. Company Details
13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Regeneron Pharmaceuticals Inc.
13.5.1 Regeneron Pharmaceuticals Inc. Company Details
13.5.2 Regeneron Pharmaceuticals Inc. Business Overview and Its Total Revenue
13.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.5.5 Regeneron Pharmaceuticals Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table
List of Tables
Table 1. Age-Related Macular Degeneration (AMD) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
Table 3. Ranking of Global Top Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Wet AMD
Table 6. Key Players of Dry AMD
Table 7. COVID-19 Impact Global Market: (Four Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Age-Related Macular Degeneration (AMD) Therapeutics Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Age-Related Macular Degeneration (AMD) Therapeutics Players to Combat Covid-19 Impact
Table 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2015-2020)
Table 16. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy
Table 22. Main Points Interviewed from Key Age-Related Macular Degeneration (AMD) Therapeutics Players
Table 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players (2015-2020)
Table 25. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019)
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
Table 29. Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Type (2015-2020)
Table 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2021-2026)
Table 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2015-2020)
Table 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2021-2026)
Table 37. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 39. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 40. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 41. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 42. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 43. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 45. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 47. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 49. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 50. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 51. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 52. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 53. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 54. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 55. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 57. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 59. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 63. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 65. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 67. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 68. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 69. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 70. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 71. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 72. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 75. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 77. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 79. Amgen Inc. Company Details
Table 80. Amgen Inc. Business Overview
Table 81. Amgen Inc. Product
Table 82. Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 83. Amgen Inc. Recent Development
Table 84. Bausch Health Companies, Inc. Company Details
Table 85. Bausch Health Companies, Inc. Business Overview
Table 86. Bausch Health Companies, Inc. Product
Table 87. Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 88. Bausch Health Companies, Inc. Recent Development
Table 89. F. Hoffmann-La Roche Ltd. Company Details
Table 90. F. Hoffmann-La Roche Ltd. Business Overview
Table 91. F. Hoffmann-La Roche Ltd. Product
Table 92. F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 93. F. Hoffmann-La Roche Ltd. Recent Development
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Product
Table 97. Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 98. Novartis AG Recent Development
Table 99. Regeneron Pharmaceuticals Inc. Company Details
Table 100. Regeneron Pharmaceuticals Inc. Business Overview
Table 101. Regeneron Pharmaceuticals Inc. Product
Table 102. Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 103. Regeneron Pharmaceuticals Inc. Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institute Case Studies
Figure 8. Other Case Studies
Figure 9. Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered
Figure 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players in 2019
Figure 15. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019
Figure 17. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Amgen Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 26. Bausch Health Companies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bausch Health Companies, Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 28. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 30. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis AG Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 32. Regeneron Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us